SLT Technology

The Ellex Solo™ is an advanced SLT (selective laser trabeculoplasty) laser which allows you to perform quick and highly accurate glaucoma laser treatment customized to each individual patient’s response. SLT is gentle and non-invasive, which means you can stimulate healthy trabecular meshwork cell regeneration and manage IOP without producing burn scar tissue.

SLT Technology, from Ellex®

The New Generation Solo™ features custom-designed optics to ensure an enhanced view of the trabecular meshwork, enabling you to perform SLT procedures faster and more accurately.

Featuring a high level of precision, Solo’s sharp-edged aiming beam ensures greater accuracy and reliability - ensuring effective patient results.

The industry’s fastest SLT firing rate at 3 shots per second, Solo’s proprietary energy tracking system provides higher shot-to-shot stability – achieving the highest safety and efficacy standards.

The New Generation Solo™ is a highly effective tool for first-line glaucoma treatments. It also pairs seamlessly with MIGS procedures – either prior to, or following, MIGS. Further, SLT can be used as adjunct therapy with drugs, and as alternative therapy when drugs fail.

Contact us

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More


Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.

The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.